Author:Sciensus
News, Cancer
Promising breakthrough for patients with rare form of cancer
Blogs/Articles, Rare diseases
Mitigating Risks in Early Access Programs: A Guide for Biotech Companies
News
Sciensus continues to extend the full range of its services across Europe
Blogs/Articles
Safety first: Profiling adverse events in cancer drug therapies
Blogs/Articles
Revolutionising Medication Adherence in Cancer Care with Digital Solutions
Blogs/Articles, Cancer
Personalising Cancer Care: The Impact of Digital PROMs Collection in Breast Cancer Treatment
Blogs/Articles
The power of patient insight: Understanding the drivers of adherence and persistence
News
Jonathan Asbridge selected as a Fellow of the American Academy of Nursing
Events, Cancer
Clinical Pharmacy Congress 2024